Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Lawmakers seek scientific review of plan to tightly regulate all fentanyl copycats

Lawmakers on the U.S. Senate Judiciary Committee urged the Trump administration to conduct a scientific review of a Justice Department-backed bill to classify all illicit chemical knockoffs of the potent painkiller fentanyl in the same legal category as heroin.

Read More »

White House scraps proposal to lower U.S. drug prices

The Trump administration scrapped a proposal for lowering prescription medicine prices, backing down from a policy that would have required health insurers to pass on billions of dollars in rebates they receive from drugmakers to Medicare patients.

Read More »

U.S. aims to cut dialysis in centers, increase transplants by 2025

The Trump administration plans to change the way it pays for kidney disease treatments to favor lower cost care at home and transplants over the current standard, dialysis clinics, top health officials said during a press briefing.

Read More »

U.S. appeals court signals sympathy to bid to strike down Obamacare

A federal appeals court panel expressed skepticism to Democratic calls to overturn the ruling of a Texas judge who found the landmark U.S. healthcare reform law unconstitutional.

Read More »

U.S. Companies Continue to Pay More in Healthcare as the Cost of Drugs Keeps Rising

The United States pays more per capita for prescription drugs than any other country in the world, which is a huge concern for patients and insurance providers.

Read More »

Trump to issue executive order seeking transparency on healthcare costs: Wall Street Journal

U.S. President Donald Trump plans to issue an executive order asking health insurers and doctors to disclose new details about healthcare costs in an attempt to improve price transparency, the Wall Street Journal reported, citing people familiar with the matter.

Read More »

The Rebate System Spikes Drug Prices, Scripps Study Confirms

As concerns over the price of prescription medicine continue to make headlines as the country barrels toward another election, a new study from the Scripps Research bolsters an argument touted by the pharmaceutical industry over the rebate system.

Read More »

House Appropriations Committee Proposes 6% Increase in FDA Funding

The House Appropriations Committee proposed a 2020 draft fiscal year funding bill. The FDA would receive a 6 percent increase in discretionary funding over 2019, amounting to a $184 million bump.

Read More »

U.S. states accuse 20 drugmakers of price fixing

U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc. of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs, state prosecutors said.

Read More »

Trump slams drugmakers, vows to let U.S. states buy cheaper medicines abroad

U.S. President Donald Trump slammed the pharmaceutical industry for high prices of prescription drugs and vowed to allow U.S. states to buy medicines from other countries if they cost less.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom